Table 2.
Test Results and Event Rates by Sex and Test Type
| Women (N=4720) | Men (N=4246) | |||||
|---|---|---|---|---|---|---|
| CTA (N=2332) | Stress (N=2388) | P-value | CTA (N=2168) | Stress (N=2078) | P-value | |
| Positive Test Result | 184/2332 (7.9%) | 274/2388 (11.5%) | <.001 | 350/2168 (16.1%) | 290/2078 (14.0%) | 0.046 |
| Multi vessel disease/Ischemia | 78/184 (42.4%) | 190/274 (69.3%) | 188/350 (53.7%) | 165/290 (56.9%) | ||
| Single vessel disease/Ischemia | 106/184 (57.6%) | 84/274 (30.7%) | 162/350 (46.3%) | 125/290 (43.1%) | ||
| Negative Test Result | 2148/2332 (92.1%) | 2114/2388 (88.5%) | <.001 | 1818/2168 (83.9%) | 1788/2078 (86.0%) | 0.046 |
| Nonbstructive CAD/Abnormal ECG with normal imaging or scar without ischemia | 1185/2148 (55.2%) | 197/2114 (9.3%) | 1276/1818 (70.2%) | 226/1788 (12.6%) | ||
| Normal anatomy/no abnormalities | 963/2148 (44.8%) | 1917/2114 (90.7%) | 542/1818 (29.8%) | 1562/1788 (87.4%) | ||
| Revascularization within 90 days | 82/2332 (3.5%) | 45/2388 (1.9%) | <.001 | 191/2168 (8.8%) | 102/2078 (4.9%) | <.001 |
| Primary Composite Endpoint: Time to Death/MI/UAH (%) | 57/2332 (2.4%) | 55/2388 (2.3%) | 0.750 | 80/2168 (3.7%) | 73/2078 (3.5%) | 0.757 |
| Individual Components (%) | 0.007 | 0.778 | ||||
| All Cause Death | 28/57 (49.1%) | 29/55 (52.7%) | 34/80 (42.5%) | 34/73 (46.6%) | ||
| MI | 5/57 (8.8%) | 15/55 (27.3%) | 19/80 (23.8%) | 14/73 (19.2%) | ||
| UAH | 24/57 (42.1%) | 11/55 (20.0%) | 27/80 (33.8%) | 25/73 (34.2%) | ||
| Secondary Composite Endpoint: Time to CV Death/MI (%) | 21/2332 (0.9%) | 35/2388 (1.5%) | 0.073 | 39/2168 (1.8%) | 35/2078 (1.7%) | 0.775 |
| Individual Components (%) | 0.203 | 0.331 | ||||
| CV Death | 15/21 (71.4%) | 19/35 (54.3%) | 19/39 (48.7%) | 21/35 (60.0%) | ||
| MI | 6/21 (28.6%) | 16/35 (45.7%) | 20/39 (51.3%) | 14/35 (40.0%) | ||
CV = cardiovascular; MI = myocardial infarction; UAH = Hospitalization for unstable angina.